Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma

B. Zimmerman, S. Niewiesk, Michael Dale Lairmore

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Human T-lymphotropic virus type-1 (HTLV-1), the first human retrovirus discovered, is the causative agent of adult T-cell leukemia/lymphoma (ATL) and a number of lymphocyte-mediated inflammatory conditions including HTLV-1-associated myelopathy/tropical spastic paraparesis. Development of animal models to study the pathogenesis of HTLV-1-associated diseases has been problematic. Mechanisms of early infection and cell-to-cell transmission can be studied in rabbits and nonhuman primates, but lesion development and reagents are limited in these species. The mouse provides a cost-effective, highly reproducible model in which to study factors related to lymphoma development and the preclinical efficacy of potential therapies against ATL. The ability to manipulate transgenic mice has provided important insight into viral genes responsible for lymphocyte transformation. Expansion of various strains of immunodeficient mice has accelerated the testing of drugs and targeted therapy against ATL. This review compares various mouse models to illustrate recent advances in the understanding of HTLV-1-associated ATL development and how improvements in these models are critical to the future development of targeted therapies against this aggressive T-cell lymphoma.

Original languageEnglish (US)
Pages (from-to)677-689
Number of pages13
JournalVeterinary Pathology
Volume47
Issue number4
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Adult T Cell Leukemia Lymphoma
Human T-lymphotropic virus 1
lymphoma
leukemia
T-lymphocytes
animal models
Tropical Spastic Paraparesis
viruses
therapeutics
Viral Genes
T-Cell Lymphoma
mice
Lymphocyte Count
Retroviridae
Lymphocyte Activation
Primates
Transgenic Mice
Lymphoma
Animal Models
lymphocyte count

Keywords

  • Animal models
  • HTLV-1
  • Lymphoma
  • Mouse
  • Retrovirus
  • Review

ASJC Scopus subject areas

  • veterinary(all)
  • Medicine(all)

Cite this

Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma. / Zimmerman, B.; Niewiesk, S.; Lairmore, Michael Dale.

In: Veterinary Pathology, Vol. 47, No. 4, 2010, p. 677-689.

Research output: Contribution to journalArticle

@article{8849bddebb2f46b0952ac227b62ecca6,
title = "Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma",
abstract = "Human T-lymphotropic virus type-1 (HTLV-1), the first human retrovirus discovered, is the causative agent of adult T-cell leukemia/lymphoma (ATL) and a number of lymphocyte-mediated inflammatory conditions including HTLV-1-associated myelopathy/tropical spastic paraparesis. Development of animal models to study the pathogenesis of HTLV-1-associated diseases has been problematic. Mechanisms of early infection and cell-to-cell transmission can be studied in rabbits and nonhuman primates, but lesion development and reagents are limited in these species. The mouse provides a cost-effective, highly reproducible model in which to study factors related to lymphoma development and the preclinical efficacy of potential therapies against ATL. The ability to manipulate transgenic mice has provided important insight into viral genes responsible for lymphocyte transformation. Expansion of various strains of immunodeficient mice has accelerated the testing of drugs and targeted therapy against ATL. This review compares various mouse models to illustrate recent advances in the understanding of HTLV-1-associated ATL development and how improvements in these models are critical to the future development of targeted therapies against this aggressive T-cell lymphoma.",
keywords = "Animal models, HTLV-1, Lymphoma, Mouse, Retrovirus, Review",
author = "B. Zimmerman and S. Niewiesk and Lairmore, {Michael Dale}",
year = "2010",
doi = "10.1177/0300985810370009",
language = "English (US)",
volume = "47",
pages = "677--689",
journal = "Veterinary Pathology",
issn = "0300-9858",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma

AU - Zimmerman, B.

AU - Niewiesk, S.

AU - Lairmore, Michael Dale

PY - 2010

Y1 - 2010

N2 - Human T-lymphotropic virus type-1 (HTLV-1), the first human retrovirus discovered, is the causative agent of adult T-cell leukemia/lymphoma (ATL) and a number of lymphocyte-mediated inflammatory conditions including HTLV-1-associated myelopathy/tropical spastic paraparesis. Development of animal models to study the pathogenesis of HTLV-1-associated diseases has been problematic. Mechanisms of early infection and cell-to-cell transmission can be studied in rabbits and nonhuman primates, but lesion development and reagents are limited in these species. The mouse provides a cost-effective, highly reproducible model in which to study factors related to lymphoma development and the preclinical efficacy of potential therapies against ATL. The ability to manipulate transgenic mice has provided important insight into viral genes responsible for lymphocyte transformation. Expansion of various strains of immunodeficient mice has accelerated the testing of drugs and targeted therapy against ATL. This review compares various mouse models to illustrate recent advances in the understanding of HTLV-1-associated ATL development and how improvements in these models are critical to the future development of targeted therapies against this aggressive T-cell lymphoma.

AB - Human T-lymphotropic virus type-1 (HTLV-1), the first human retrovirus discovered, is the causative agent of adult T-cell leukemia/lymphoma (ATL) and a number of lymphocyte-mediated inflammatory conditions including HTLV-1-associated myelopathy/tropical spastic paraparesis. Development of animal models to study the pathogenesis of HTLV-1-associated diseases has been problematic. Mechanisms of early infection and cell-to-cell transmission can be studied in rabbits and nonhuman primates, but lesion development and reagents are limited in these species. The mouse provides a cost-effective, highly reproducible model in which to study factors related to lymphoma development and the preclinical efficacy of potential therapies against ATL. The ability to manipulate transgenic mice has provided important insight into viral genes responsible for lymphocyte transformation. Expansion of various strains of immunodeficient mice has accelerated the testing of drugs and targeted therapy against ATL. This review compares various mouse models to illustrate recent advances in the understanding of HTLV-1-associated ATL development and how improvements in these models are critical to the future development of targeted therapies against this aggressive T-cell lymphoma.

KW - Animal models

KW - HTLV-1

KW - Lymphoma

KW - Mouse

KW - Retrovirus

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=77954889409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954889409&partnerID=8YFLogxK

U2 - 10.1177/0300985810370009

DO - 10.1177/0300985810370009

M3 - Article

C2 - 20442421

AN - SCOPUS:77954889409

VL - 47

SP - 677

EP - 689

JO - Veterinary Pathology

JF - Veterinary Pathology

SN - 0300-9858

IS - 4

ER -